Inactivated influenza vaccine

45 marketed 53 in Phase 3 2 in Phase 2

This page covers all Inactivated influenza vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting H1N1 influenza virus hemagglutinin and neuraminidase antigens, H5N1 influenza virus surface antigens (hemagglutinin and neuraminidase), Influenza hemagglutinin (HA) protein.

Targets

H1N1 influenza virus hemagglutinin and neuraminidase antigens · H5N1 influenza virus surface antigens (hemagglutinin and neuraminidase) · Influenza hemagglutinin (HA) protein · Influenza virus hemagglutinin and neuraminidase antigens; MF59 acts as immunological adjuvant · Influenza virus surface antigens (hemagglutinin and neuraminidase)

Marketed (45)

Phase 3 pipeline (53)

Phase 2 pipeline (2)